메뉴 건너뛰기




Volumn 3, Issue 2, 2010, Pages 47-52

DNA and histone deacetylases as targets for neuroblastoma treatment

Author keywords

DNA damaging anticancer drugs; inhibitors of histone deacetylases; mechanisms of acticancer effects of drugs; neuroblastoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DNA; DOXORUBICIN; ELLIPTICINE; ETOPOSIDE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; TRICHOSTATIN A; VALPROIC ACID;

EID: 77956314911     PISSN: 13376853     EISSN: 13379569     Source Type: Journal    
DOI: 10.2478/v10102-010-0010-6     Document Type: Review
Times cited : (5)

References (64)
  • 1
    • 0023617219 scopus 로고
    • Multimodal action of antitumor agents on DNA: The ellipticine series
    • Auclair C. (1987). Multimodal action of antitumor agents on DNA: The ellipticine series. Arch Biochem Biophys 259: 1-14.
    • (1987) Arch Biochem Biophys , vol.259 , pp. 1-14
    • Auclair, C.1
  • 3
    • 0025826599 scopus 로고
    • Expression of mdr-1/P-glycoprotein in human neuroblastoma
    • Bates SE, Shieh CY and Tsokos M. (1991). Expression of mdr-1/P-glycoprotein in human neuroblastoma. Am J Pathol 139: 305-315.
    • (1991) Am J Pathol , vol.139 , pp. 305-315
    • Bates, S.E.1    Shieh, C.Y.2    Tsokos, M.3
  • 6
    • 33748451151 scopus 로고    scopus 로고
    • Anticancer activities of histone deacetylase inhibitors
    • Bolden JE, Peart MJ and Johnstone RW. (2006). Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 5: 769-784.
    • (2006) Nat Rev Drug Discov , vol.5 , pp. 769-784
    • Bolden, J.E.1    Peart, M.J.2    Johnstone, R.W.3
  • 7
    • 0037366067 scopus 로고    scopus 로고
    • Neuroblastoma: Biological insights into a clinical enigma
    • Brodeur GM. (2003). Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3: 203-216.
    • (2003) Nat Rev Cancer , vol.3 , pp. 203-216
    • Brodeur, G.M.1
  • 8
    • 33751505528 scopus 로고    scopus 로고
    • Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells
    • Catalano MG, Fortunati N, Pugliese M, Poli R, Bosco O, Mastrocola R, Aragno M and Boccuzzi G. (2006). Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells. J Endocrinol 191: 465-472.
    • (2006) J Endocrinol , vol.191 , pp. 465-472
    • Catalano, M.G.1    Fortunati, N.2    Pugliese, M.3    Poli, R.4    Bosco, O.5    Mastrocola, R.6    Aragno, M.7    Boccuzzi, G.8
  • 12
    • 0033093979 scopus 로고    scopus 로고
    • Antimitotic drugs cause increased tumorigenicity of multidrug resistant cells
    • Emanuel SL, Chamberlin HA and Cohen D. (1999). Antimitotic drugs cause increased tumorigenicity of multidrug resistant cells. Int J Oncol 14: 487-494.
    • (1999) Int J Oncol , vol.14 , pp. 487-494
    • Emanuel, S.L.1    Chamberlin, H.A.2    Cohen, D.3
  • 13
    • 0027104314 scopus 로고
    • Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: Structure-activity relationships
    • FosśP, ReńB, Charra M, Paoletti C and Saucier JM (1992) Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: structure-activity relationships. Mol Pharmacol 42:590-595.
    • (1992) Mol Pharmacol , vol.42 , pp. 590-595
    • Fosś, P.1    Reń, B.2    Charra, M.3    Paoletti, C.4    Saucier, J.M.5
  • 14
    • 0029015354 scopus 로고
    • Topoisomerase II binds to ellipticine in the absence or presence of DNA. Characterization of enzyme-drug interactions by fl uorescence spectroscopy
    • Froelich-Ammon SJ, Patchan MW, Osheroff N and Thompson RB. (1995). Topoisomerase II binds to ellipticine in the absence or presence of DNA. Characterization of enzyme-drug interactions by fl uorescence spectroscopy. J Biol Chem 270: 4998-5004.
    • (1995) J Biol Chem , vol.270 , pp. 4998-5004
    • Froelich-Ammon, S.J.1    Patchan, M.W.2    Osheroff, N.3    Thompson, R.B.4
  • 15
    • 33947153003 scopus 로고    scopus 로고
    • Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhood
    • Furchert SE, Lanvers-Kaminsky C, Júgens H, Jung M, Loidl A and Fŕwald MC. (2007). Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhood. Int J Cancer 120: 1787-1794.
    • (2007) Int J Cancer , vol.120 , pp. 1787-1794
    • Furchert, S.E.1    Lanvers-Kaminsky, C.2    Júgens, H.3    Jung, M.4    Loidl, A.5    Fŕwald, M.C.6
  • 17
    • 0037026635 scopus 로고    scopus 로고
    • Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells
    • Hopkins-Donaldson S, Yan P, Bourloud KB, Muhlethaler A, Bodmer JL and Gross N. (2002). Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells. Oncogene 21: 6132-37.
    • (2002) Oncogene , vol.21 , pp. 6132-6137
    • Hopkins-Donaldson, S.1    Yan, P.2    Bourloud, K.B.3    Muhlethaler, A.4    Bodmer, J.L.5    Gross, N.6
  • 18
    • 13944280578 scopus 로고    scopus 로고
    • Effects of suberoylanilide hydroxamic acid and trichostatin A on induction of cytochrome P450 enzymes and benzo[a] pyrene DNA adduct formation in human cells
    • Hooven LA, Mahadevan B, Keshava C, Johns C, Pereira C, Desai D, Amin S, Weston A and Baird WM. (2005). Effects of suberoylanilide hydroxamic acid and trichostatin A on induction of cytochrome P450 enzymes and benzo[a] pyrene DNA adduct formation in human cells. Bioorg Med Chem Lett 15: 1283-1287
    • (2005) Bioorg Med Chem Lett , vol.15 , pp. 1283-1287
    • Hooven, L.A.1    Mahadevan, B.2    Keshava, C.3    Johns, C.4    Pereira, C.5    Desai, D.6    Amin, S.7    Weston, A.8    Baird, W.M.9
  • 19
    • 77956329493 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors valproate and trichostatin A are toxic to neuroblastoma cells and modulate cytochrome P450 1A1, 1B1 and 3A4 expression in these cells
    • HÝebǎkováJ, PoljakováJ, Eckschlager T, Hrabta J, Prochýka P, Smutń S and StiborováM. (2009). Histone deacetylase inhibitors valproate and trichostatin A are toxic to neuroblastoma cells and modulate cytochrome P450 1A1, 1B1 and 3A4 expression in these cells. Interdisc Toxicol 2: 205-210.
    • (2009) Interdisc Toxicol , vol.2 , pp. 205-210
    • Hýebǎková, J.1    Poljaková, J.2    Eckschlager, T.3    Hrabta, J.4    Prochýka, P.5    Smutń, S.6    Stiborová, M.7
  • 20
    • 0242610850 scopus 로고    scopus 로고
    • Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA
    • Kim MS, Blake M, Baek JH, Kohlhagen G, Pommier Y and Carrier F. (2003). Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. Cancer Res 63: 7291-7300.
    • (2003) Cancer Res , vol.63 , pp. 7291-7300
    • Kim, M.S.1    Blake, M.2    Baek, J.H.3    Kohlhagen, G.4    Pommier, Y.5    Carrier, F.6
  • 24
    • 0031791723 scopus 로고    scopus 로고
    • Presence of classical multidrug resistance and P-glycoprotein expression in human neuroblastoma cells
    • Kurowski C and Berthold F. (1998). Presence of classical multidrug resistance and P-glycoprotein expression in human neuroblastoma cells. Ann Oncol 9: 1009-1014.
    • (1998) Ann Oncol , vol.9 , pp. 1009-1014
    • Kurowski, C.1    Berthold, F.2
  • 25
    • 77950815766 scopus 로고    scopus 로고
    • Pharmacogenetics of target genes across doxorubicin disposition pathway: A review
    • Lal S, Mahajan A, Chen WN and Chowbay B. (2010). Pharmacogenetics of target genes across doxorubicin disposition pathway: a review. Curr Drug Metab 11: 115-128.
    • (2010) Curr Drug Metab , vol.11 , pp. 115-128
    • Lal, S.1    Mahajan, A.2    Chen, W.N.3    Chowbay, B.4
  • 27
    • 18144373452 scopus 로고    scopus 로고
    • Valproic acid alters chromatin structure by regulation of chromatin modulation proteins
    • Marchion DC, Bicaku E, Daud AI, Sullivan DM and Munster PN. (2005a) Valproic acid alters chromatin structure by regulation of chromatin modulation proteins. Cancer Res 65: 3815-3822.
    • (2005) Cancer Res , vol.65 , pp. 3815-3822
    • Marchion, D.C.1    Bicaku, E.2    Daud, A.I.3    Sullivan, D.M.4    Munster, P.N.5
  • 28
    • 30344443991 scopus 로고    scopus 로고
    • In vivo synergy between topoisomerase II and histone deacetylase inhibitors: Predictive correlates
    • Marchion DC, Bicaku E, Daud AI, Sullivan DM and Munster PN. (2005b) In vivo synergy between topoisomerase II and histone deacetylase inhibitors: predictive correlates. Mol. Cancer Ther 4: 1993-2000.
    • (2005) Mol. Cancer Ther , vol.4 , pp. 1993-2000
    • Marchion, D.C.1    Bicaku, E.2    Daud, A.I.3    Sullivan, D.M.4    Munster, P.N.5
  • 29
    • 0033034390 scopus 로고    scopus 로고
    • Molecular biology of neuroblastoma
    • Maris JM and Matthay KK. (1999). Molecular biology of neuroblastoma. J Clin Oncol 17: 2264-2279.
    • (1999) J Clin Oncol , vol.17 , pp. 2264-2279
    • Maris, J.M.1    Matthay, K.K.2
  • 33
    • 0025789701 scopus 로고
    • Cutaneous NAD(P)H: Quinone reductase: A xenobiotica-metabolizing enzyme with potential cancer and oxidation stress-protecting properties
    • Merk HF and Jugert FK. (1991). Cutaneous NAD(P)H: quinone reductase: a xenobiotica-metabolizing enzyme with potential cancer and oxidation stress-protecting properties. Skin Pharmacol 4 Suppl 1: 95-100.
    • (1991) Skin Pharmacol , vol.4 , Issue.SUPPL. 1 , pp. 95-100
    • Merk, H.F.1    Jugert, F.K.2
  • 34
    • 16644379041 scopus 로고    scopus 로고
    • Valproic acid and interferon-alpha synergistically inhibit neuroblastoma cell growth in vitro and in vivo
    • Michaelis M, Suhan T, Cinatl J, Driever PH and Cinatl J Jr. (2004). Valproic acid and interferon-alpha synergistically inhibit neuroblastoma cell growth in vitro and in vivo. Int J Oncol 25: 1795-1799.
    • (2004) Int J Oncol , vol.25 , pp. 1795-1799
    • Michaelis, M.1    Suhan, T.2    Cinatl, J.3    Driever, P.H.4    Cinatl Jr., J.5
  • 38
    • 0030031845 scopus 로고    scopus 로고
    • Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma
    • Norris MD, Bordow SB, Marshall GM, Haber PS, Cohn SL and Haber M. (1996). Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N Engl J Med 334: 231-238.
    • (1996) N Engl J Med , vol.334 , pp. 231-238
    • Norris, M.D.1    Bordow, S.B.2    Marshall, G.M.3    Haber, P.S.4    Cohn, S.L.5    Haber, M.6
  • 39
    • 1042302133 scopus 로고    scopus 로고
    • Modulation of mutagenicity by phosphorylation of mutagen-metabolizing enzymes
    • Oesch-Bartlmowicz B and Oesch F. (2004 ) Modulation of mutagenicity by phosphorylation of mutagen-metabolizing enzymes. Arch Biochem Biophys 423: 31-36.
    • (2004) Arch Biochem Biophys , vol.423 , pp. 31-36
    • Oesch-Bartlmowicz, B.1    Oesch, F.2
  • 40
    • 0032513236 scopus 로고    scopus 로고
    • The binding properties and biological activities of Bcl-2 and Bax in cells exposed to apoptotic stimuli
    • Otter I, Conus S, Ravn U, Rager M, Olivier R, Monney L, Fabbro D and Borner C. (1998). The binding properties and biological activities of Bcl-2 and Bax in cells exposed to apoptotic stimuli. J Biol Chem 273: 6110-6120.
    • (1998) J Biol Chem , vol.273 , pp. 6110-6120
    • Otter, I.1    Conus, S.2    Ravn, U.3    Rager, M.4    Olivier, R.5    Monney, L.6    Fabbro, D.7    Borner, C.8
  • 42
    • 77956325035 scopus 로고    scopus 로고
    • The comparison of cytotoxicity of anticancer drug doxorubicin and ellipticine to human neuroblastoma cells
    • PoljakováJ, Eckschlager T, HÝebǎkováJ, Hrabta J and StiborováM. (2008). The comparison of cytotoxicity of anticancer drug doxorubicin and ellipticine to human neuroblastoma cells. Interdisc Toxicol 1: 186-189.
    • (2008) Interdisc Toxicol , vol.1 , pp. 186-189
    • Poljaková, J.1    Eckschlager, T.2    Hýebǎková, J.3    Hrabta, J.4    Stiborová, M.5
  • 44
    • 34249033131 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors: Molecular and biological activity as a premise to clinical application
    • Santini V, Gozzini A and Ferrari G. (2007). Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application. Curr Drug Metab 8: 383-393.
    • (2007) Curr Drug Metab , vol.8 , pp. 383-393
    • Santini, V.1    Gozzini, A.2    Ferrari, G.3
  • 45
    • 0027953894 scopus 로고
    • Highfi eld NMR and restrained molecular modeling studies on a DNA heteroduplex containing a modifi ed apurinic abasic site in the form of covalently linked 9-aminoellipticine
    • Singh MP, Hill GC, Peoch D, Rayner B, Inabach JL and Lown JW. (1994). Highfi eld NMR and restrained molecular modeling studies on a DNA heteroduplex containing a modifi ed apurinic abasic site in the form of covalently linked 9-aminoellipticine. Biochemistry 33: 10271-10285.
    • (1994) Biochemistry , vol.33 , pp. 10271-10285
    • Singh, M.P.1    Hill, G.C.2    Peoch, D.3    Rayner, B.4    Inabach, J.L.5    Lown, J.W.6
  • 46
    • 33748458071 scopus 로고    scopus 로고
    • Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene
    • Song X, Liu X, Chi W, Liu Y, Wei L, Wang X and Yu J. (2006). Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene. Cancer Chemother Pharmacol 58: 776-784.
    • (2006) Cancer Chemother Pharmacol , vol.58 , pp. 776-784
    • Song, X.1    Liu, X.2    Chi, W.3    Liu, Y.4    Wei, L.5    Wang, X.6    Yu, J.7
  • 47
    • 0035894174 scopus 로고    scopus 로고
    • The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts
    • StiborováM, Bieler CA, Wiessler M and Frei E. (2001). The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts. Biochem Pharmacol 62: 675-684.
    • (2001) Biochem Pharmacol , vol.62 , pp. 675-684
    • Stiborová, M.1    Bieler, C.A.2    Wiessler, M.3    Frei, E.4
  • 49
    • 12244292673 scopus 로고    scopus 로고
    • Rat microsomes activating the anticancer drug ellipticine to species covalently binding to deoxyguanosine in DNA are a suitable model mimicking ellipticine bioactivation in humans
    • StiborováM, StiborováRupertováM, Bǒek-DohalskL, Wiessler M, Frei E(2003b) Rat microsomes activating the anticancer drug ellipticine to species covalently binding to deoxyguanosine in DNA are a suitable model mimicking ellipticine bioactivation in humans. Chem Res Toxicol 16:38-47.
    • (2003) Chem Res Toxicol , vol.16 , pp. 38-47
    • Stiborová, M.1    Stiborovárupertová, M.2    Bǒek-Dohalsk, L.3    Wiessler, M.4    Frei, E.5
  • 52
    • 33845624680 scopus 로고    scopus 로고
    • Mammalian peroxidases activate anticancer drug ellipticine to intermediates forming deoxyguanosine adducts in DNA identical to those found in vivo and generated from 12-hydroxyellipticine and 13-hydroxyellipticine
    • StiborováM, PoljakováJ, RyŝlaváH, Drǎ̂sk M, Eckschlager T and Frei E. (2007a) Mammalian peroxidases activate anticancer drug ellipticine to intermediates forming deoxyguanosine adducts in DNA identical to those found in vivo and generated from 12-hydroxyellipticine and 13-hydroxyellipticine. Int J Cancer 120: 243-251.
    • (2007) Int J Cancer , vol.120 , pp. 243-251
    • Stiborová, M.1    Poljaková, J.2    Ryŝlavá, H.3    Drǎ̂sk, M.4    Eckschlager, T.5    Frei, E.6
  • 53
    • 34248652696 scopus 로고    scopus 로고
    • Formation and persistence of DNA adducts of anticancer drug ellipticine in rats
    • StiborováM, RupertováM, AimováD, RyŝlaváH and Frei E. (2007b) Formation and persistence of DNA adducts of anticancer drug ellipticine in rats. Toxicology 236: 50-60.
    • (2007) Toxicology , vol.236 , pp. 50-60
    • Stiborová, M.1    Rupertová, M.2    Aimová, D.3    Ryŝlavá, H.4    Frei, E.5
  • 55
    • 77956298408 scopus 로고    scopus 로고
    • Cytochrome P450- and peroxidase-mediated oxidation of anticancer alkaloid ellipticine dictates its antitumor effi ciency
    • in press
    • StiborováM, RupertováM and Frei E. (2010). Cytochrome P450- and peroxidase-mediated oxidation of anticancer alkaloid ellipticine dictates its antitumor effi ciency. Biochim Biophys Acta, in press.
    • (2010) Biochim Biophys Acta
    • Stiborová, M.1    Rupertová, M.2    Frei, E.3
  • 56
    • 0033039024 scopus 로고    scopus 로고
    • Human neuroblastoma: From basic science to clinical debut of cellular oncogenes
    • Schwab M. (1999). Human neuroblastoma: from basic science to clinical debut of cellular oncogenes. Naturwissenschaften 86: 71-78.
    • (1999) Naturwissenschaften , vol.86 , pp. 71-78
    • Schwab, M.1
  • 58
    • 31544446626 scopus 로고    scopus 로고
    • Cancer treatment and pharmacogenetics of cytochrome P450 enzymes
    • van Schaik R. (2005). Cancer treatment and pharmacogenetics of cytochrome P450 enzymes. Invest New Drugs 23: 513-522.
    • (2005) Invest New Drugs , vol.23 , pp. 513-522
    • Van Schaik, R.1
  • 59
    • 46149095280 scopus 로고    scopus 로고
    • CYP450 pharmacogenetics for personalizing cancer therapy
    • van Schaik RH. (2008). CYP450 pharmacogenetics for personalizing cancer therapy. Drug Resist Updat 11: 77-98
    • (2008) Drug Resist Updat , vol.11 , pp. 77-98
    • Van Schaik, R.H.1
  • 60
    • 31844434762 scopus 로고    scopus 로고
    • Diff erentiation, proliferation and adhesion of human neuroblastoma cells after treatment with retinoic acid
    • Voigt A, Hartmann P and Zintl F. (2000). Diff erentiation, proliferation and adhesion of human neuroblastoma cells after treatment with retinoic acid. Cell Adhes Commun 7: 423-440.
    • (2000) Cell Adhes Commun , vol.7 , pp. 423-440
    • Voigt, A.1    Hartmann, P.2    Zintl, F.3
  • 61
    • 52449133102 scopus 로고    scopus 로고
    • CYP2B6: New insights into a historically overlooked cytochrome P450 isozyme
    • Wang H and Tompkins L. (2008). CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme. Curr Drug Metab 9: 598-610.
    • (2008) Curr Drug Metab , vol.9 , pp. 598-610
    • Wang, H.1    Tompkins, L.2
  • 62
    • 0037190798 scopus 로고    scopus 로고
    • Genetic parameters of neuroblastomas
    • Westermann F and Schwab M. (2002). Genetic parameters of neuroblastomas. Cancer Lett 184: 127-147.
    • (2002) Cancer Lett , vol.184 , pp. 127-147
    • Westermann, F.1    Schwab, M.2
  • 64
    • 0037276902 scopus 로고    scopus 로고
    • The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells
    • Zhu WG and Otterson GA. (2003). The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells. Curr Med Chem Anticancer Agents 3: 187-199.
    • (2003) Curr Med Chem Anticancer Agents , vol.3 , pp. 187-199
    • Zhu, W.G.1    Otterson, G.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.